Metacrine is a clinical-stage biopharmaceutical company focused on discovering and developing differentiated therapies for patients with liver and gastrointestinal (GI) diseases.
Metacrine, Inc., a San Diego, CA-based innovative biotechnology company developing therapies to benefit patients with liver, gastrointestinal and metabolic diseases, completed a $65m Series C financing
